Literature DB >> 24916398

Snail and Slug mediate tamoxifen resistance in breast cancer cells through activation of EGFR-ERK independent of epithelial-mesenchymal transition.

Yan Jiang1, Xiaotong Zhao1, Qian Xiao1, Qingbo Liu1, Keshuo Ding2, Fei Yu1, Rui Zhang1, Tao Zhu2, Gaoxiang Ge3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24916398     DOI： 10.1093/jmcb/mju019

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN： 1759-4685            Impact factor:   6.216


× No keyword cloud information.
  15 in total

Review 1.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 2.  Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Authors:  Jente van Staalduinen; David Baker; Peter Ten Dijke; Hans van Dam
Journal:  Oncogene       Date:  2018-07-12       Impact factor: 9.867

3.  CCR7 pathway induces epithelial-mesenchymal transition through up-regulation of Snail signaling in gastric cancer.

Authors:  Jianping Zhang; Yunzhe Zhou; Yonggang Yang
Journal:  Med Oncol       Date:  2015-01-09       Impact factor: 3.064

4.  Revisiting Epithelial Carcinogenesis.

Authors:  Luis Fernando Méndez-López
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

5.  Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells.

Authors:  Yung-Chieh Chang; Chun Hei Antonio Cheung; Yao-Lung Kuo
Journal:  Front Cell Dev Biol       Date:  2020-06-30

Review 6.  Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.

Authors:  Benjamin Yaw Owusu; Robert Galemmo; James Janetka; Lidija Klampfer
Journal:  Cancers (Basel)       Date:  2017-04-17       Impact factor: 6.639

7.  SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.

Authors:  Carla L Alves; Daniel Elias; Maria B Lyng; Martin Bak; Henrik J Ditzel
Journal:  Breast Cancer Res       Date:  2018-06-19       Impact factor: 6.466

8.  CBP-mediated Slug acetylation stabilizes Slug and promotes EMT and migration of breast cancer cells.

Authors:  Xiaoyan Dai; Yanli Xin; Weizhi Xu; Xinxia Tian; Xiaofan Wei; Hongquan Zhang
Journal:  Sci China Life Sci       Date:  2020-07-29       Impact factor: 6.038

9.  A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells.

Authors:  Sarthak Sahoo; Ashutosh Mishra; Harsimran Kaur; Kishore Hari; Srinath Muralidharan; Susmita Mandal; Mohit Kumar Jolly
Journal:  NAR Cancer       Date:  2021-07-09

10.  CCAR1 5' UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance.

Authors:  Gaopeng Li; Xiaoli Wu; Wenchang Qian; Huayong Cai; Xinbao Sun; Weijie Zhang; Sheng Tan; Zhengsheng Wu; Pengxu Qian; Keshuo Ding; Xuefei Lu; Xiao Zhang; Hong Yan; Haifeng Song; Shouhong Guang; Qingfa Wu; Peter E Lobie; Ge Shan; Tao Zhu
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.